Bicyclol - CAS 118159-48-1

Bicyclol (SY801) (SY 801) is an anti-hepatitis drug. Oral administration of bicyclol normalizes the elevated serum transaminases (ALT, AST) by 50% in chronic viral hepatitis B and C, and also has a certain level of inhibiting HBV and HCV replication. In combination therapy of bicyclol with interferon alpha, lamivudine and adefovir dipivoxil in HBV or HCV, bicyclol may reduce YMDD mutant and side effects and increase the anti-viral efficacy.

GST, TNF, CDK, ROS, Interleukin, HBV, P-gp, Microtubule Associated, ERK, Autophagy, mTOR, JNK, Serine/threonin kinase, HSP, Ferroptosis, Bcl-2 Family, NF-κB, p38 MAPK, HCV Protease, Apoptosis, Reactive Oxygen Species

Proteases/Proteasome, NF-κB, Cytoskeletal Signaling, Microbiology/Virology, Oxidation-Reduction, Apoptosis, Immunology/Inflammation, Metabolism, Membrane transporter/Ion channel, Neuroscience, MAPK, PI3K/Akt/mTOR signaling, Autophagy, Cell Cycle/Checkpoint

118110

0.9988

C19H18O9

390.34

COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1CO

-20°C

Ice Packs

Small Compound